Therefore, identified upregulated secretory markers YWHAB, SFN, TXNDC12, and MYL6B show strong potential in establishing a battery of breast cancer biomarkers alongside pri-miR526b and pri-miR655. Here, MYL6B is linked to breast carcinoma.